HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals

University of Miami

Status: Completed

Conditions: Cervical Cancer Screening

Treatments: Behavioral: HPV self-sampling

Study type: Interventional

Funder types: Other

Identifiers

NCT03222817

20170329

Details and patient eligibility

About

The proposed study will examine the implementation of a Human Papillomavirus (HPV) self-sampling intervention for unscreened and under-screened transgender men and transmasculine individuals living in South Florida. The study will enroll participants to receive this cervical cancer screening intervention in community venues. The purpose of this study is to pilot the self-sampler for feasibility and acceptability within this underserved population.

Enrollment: 10 patients

Sex: Female

Ages: 25 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Self-identify as transgender male or as transmasculine

  • Assigned female sex at birth
  • English speaking
  • ages 25-65 years
  • report not having had a pap smear in the last three years
  • if age 30 and over, report not having a Pap smear/HPV co-test in the past 5 years

Exclusion criteria

• • Those who report having had a hysterectomy

  • Those who report having history of cervical cancer
  • Adults unable to consent
  • Those who are pregnant
  • Prisoners

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

HPV Self-sampling

Experimental group

Description:

All participants will receive HPV self-sampling. HPV self-sampling allows an individual to screen themselves for cervical cancer in private, using a device that is similar to a tampon.

Treatment:

Behavioral: HPV self-sampling